Gelatinous transformation of bone marrow following chemotherapy for myeloma.
Gelatinous transformation of the marrow (GTBM) has been associated with various conditions. We present a unique case of GTBM in a patient with myeloma following treatment with Melphalan.
Mathew
M
M
Department of Pathology, Kasturba Medical College, Manipal.
Mathews
I
I
Manohar
C
C
Rao
S
S
D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001284:Atrophy; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology*; D005780:Gelatin / Q000378:metabolism; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008558:Melphalan / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged
D018906:Antineoplastic Agents, Alkylating; D005780:Gelatin; D008558:Melphalan